193 related articles for article (PubMed ID: 25280437)
1. Survey of pediatricians in Germany reveals important challenges for possible implementation of meningococcal B vaccination.
Takla A; Wichmann O; Koch J; Terhardt M; Hellenbrand W
Vaccine; 2014 Nov; 32(48):6349-55. PubMed ID: 25280437
[TBL] [Abstract][Full Text] [Related]
2. Parental awareness and utilization of meningococcal serogroup B vaccines in the United States.
Srivastava A; Dempsey A; Galitsky A; Fahimi M; Huang L
BMC Public Health; 2020 Jul; 20(1):1109. PubMed ID: 32664872
[TBL] [Abstract][Full Text] [Related]
3. Parental awareness of Meningococcal B vaccines and willingness to vaccinate their teens.
Basta NE; Becker AB; Li Q; Nederhoff D
Vaccine; 2019 Jan; 37(4):670-676. PubMed ID: 30587431
[TBL] [Abstract][Full Text] [Related]
4. The introduction of the meningococcal B (MenB) vaccine (Bexsero®) into the national infant immunisation programme--New challenges for public health.
Ladhani SN; Campbell H; Parikh SR; Saliba V; Borrow R; Ramsay M
J Infect; 2015 Dec; 71(6):611-4. PubMed ID: 26433141
[TBL] [Abstract][Full Text] [Related]
5. Timing of adolescent meningococcal conjugate vaccination attitudes and practices of pediatricians and family medicine physicians.
Allison MA; Cohn AC; Stokley S; Crane LA; O'Leary ST; Hurley LP; Babbel CI; Dong F; Gahm C; Temte JL; Kempe A
Am J Prev Med; 2011 Dec; 41(6):581-7. PubMed ID: 22099234
[TBL] [Abstract][Full Text] [Related]
6. United States Physicians' Knowledge, Attitudes, and Practices Regarding Meningococcal Vaccination for Healthy Adolescents and Young Adults.
Herrera-Restrepo O; Bunniran S; Mond T; Davenport E; Wang J; Sweeney C; Marshall GS
J Adolesc Health; 2024 Jun; 74(6):1131-1138. PubMed ID: 38363244
[TBL] [Abstract][Full Text] [Related]
7. Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease.
Hellenbrand W; Koch J; Harder T; Bogdan C; Heininger U; Tenenbaum T; Terhardt M; Vogel U; Wichmann O; von Kries R
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1314-43. PubMed ID: 26487381
[TBL] [Abstract][Full Text] [Related]
8. A physician's guide to the 2-dose schedule of MenB-FHbp vaccine.
McDaniel A; Dempsey A; Srivastava A
Hum Vaccin Immunother; 2019; 15(11):2729-2737. PubMed ID: 30932730
[TBL] [Abstract][Full Text] [Related]
9. UK parents' attitudes towards meningococcal group B (MenB) vaccination: a qualitative analysis.
Jackson C; Yarwood J; Saliba V; Bedford H
BMJ Open; 2017 May; 7(4):e012851. PubMed ID: 28473508
[TBL] [Abstract][Full Text] [Related]
10. Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine - Advisory Committee on Immunization Practices, 2016.
Patton ME; Stephens D; Moore K; MacNeil JR
MMWR Morb Mortal Wkly Rep; 2017 May; 66(19):509-513. PubMed ID: 28520709
[TBL] [Abstract][Full Text] [Related]
11. Disparities in healthcare providers' interpretations and implementations of ACIP's meningococcal vaccine recommendations.
Huang L; Goren A; Lee LK; Li VW; Dempsey A; Srivastava A
Hum Vaccin Immunother; 2020 Apr; 16(4):933-944. PubMed ID: 31634035
[TBL] [Abstract][Full Text] [Related]
12. Awareness, Attitudes, and Practices Toward Meningococcal B Vaccine among Pediatricians in Italy.
Ferrara P; Stromillo L; Albano L
Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30513993
[No Abstract] [Full Text] [Related]
13. Adoption of Serogroup B Meningococcal Vaccine Recommendations.
Kempe A; Allison MA; MacNeil JR; O'Leary ST; Crane LA; Beaty BL; Hurley LP; Brtnikova M; Lindley MC; Albert AP
Pediatrics; 2018 Sep; 142(3):. PubMed ID: 30126935
[TBL] [Abstract][Full Text] [Related]
14. Prevention of invasive diseases: strategies to increase vaccination coverage in children and adolescents.
Zoppi G; Trucchi C
J Prev Med Hyg; 2012 Jun; 53(2):125-9. PubMed ID: 23240175
[TBL] [Abstract][Full Text] [Related]
15. Pediatricians' preferences for infant meningococcal vaccination.
Poulos C; Reed Johnson F; Krishnarajah G; Anonychuk A; Misurski D
Value Health; 2015 Jan; 18(1):67-77. PubMed ID: 25595236
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study.
Parikh SR; Andrews NJ; Beebeejaun K; Campbell H; Ribeiro S; Ward C; White JM; Borrow R; Ramsay ME; Ladhani SN
Lancet; 2016 Dec; 388(10061):2775-2782. PubMed ID: 28100432
[TBL] [Abstract][Full Text] [Related]
17. Awareness, attitudes, and practices on meningococcal serogroup B vaccination in the United States among parents of older adolescents and among young adults.
Herrera-Restrepo O; Zhou Z; Krishnan A; Conley WJ; Oladele E; Multani JK; Tuly R; Shi L; Chen CC; Preiss S; Clements DE
Curr Med Res Opin; 2024 Jan; 40(1):125-140. PubMed ID: 38032143
[TBL] [Abstract][Full Text] [Related]
18. Understanding Factors Affecting University A Students' Decision to Receive an Unlicensed Serogroup B Meningococcal Vaccine.
Breakwell L; Vogt TM; Fleming D; Ferris M; Briere E; Cohn A; Liang JL
J Adolesc Health; 2016 Oct; 59(4):457-64. PubMed ID: 27523976
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero(®) to reduce meningococcal group B disease in Germany.
Christensen H; Irving T; Koch J; Trotter CL; Ultsch B; Weidemann F; Wichmann O; Hellenbrand W
Vaccine; 2016 Jun; 34(29):3412-9. PubMed ID: 27109566
[TBL] [Abstract][Full Text] [Related]
20. Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: A Discrete Choice Experiment.
Marshall HS; Chen G; Clarke M; Ratcliffe J
Vaccine; 2016 Jan; 34(5):671-677. PubMed ID: 26740249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
